April 12, 2021 | Board Member (No Photo Displayed)| Leadership
Matthew Gantz is President and Chief Executive Officer of Castle Creek Biosciences, Inc., and a member of the company’s Board of Directors. An accomplished life sciences executive with more than 25 years of experience in the specialty biopharmaceutical and medical device industries, Mr. Gantz previously served as Chief Executive Officer of OxThera AB. Prior to […]
Read MoreJanuary 05, 2022 | Leadership
Joseph Lillegard is Chief Scientific Officer of Castle Creek Biosciences, Inc. He led a cell and gene therapy research lab at Mayo Clinic with a focus on correction strategies of inborn errors of metabolism of the liver. Based on this research, Dr. Lillegard co-founded Cytotheryx, Inc., a hepatocyte cell-based therapy company, and Novavita Thera, Inc., […]
Read MoreJuly 02, 2020 | Leadership
Mr. Hesselberg is Senior Vice President of Regulatory Affairs at Castle Creek Biosciences, Inc. He brings more than 30 years of experience in the biopharmaceutical industry, including over 20 years in regulatory affairs drug and biologics development. Prior to joining Castle Creek, Mr. Hesselberg held various leadership positions at Immunex Corporation, ICOS Corporation, GTX Inc, […]
Read More